Sandbox Reserved 432
From Proteopedia
(Difference between revisions)
(→Overall Structure) |
(→Overall Structure) |
||
| Line 24: | Line 24: | ||
==Overall Structure== | ==Overall Structure== | ||
<Structure load='4uxl' size='300' frame='true' align='right' caption='4uxl, Overall Structure' scene='48/483889/Overall_structure/1'>Overall Structure</scene> | <Structure load='4uxl' size='300' frame='true' align='right' caption='4uxl, Overall Structure' scene='48/483889/Overall_structure/1'>Overall Structure</scene> | ||
| - | <br><br> | + | <br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> |
b. Overall structure | b. Overall structure | ||
Revision as of 06:55, 24 February 2016
| This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439. |
Protein complex with cancer drug Alecensa-Alectinib (4uxl)
by Laura Feeley, Katie Kwan, Daniel Peters, Ishtiaq Rafiyu, Luke Ruksnaitis
Student Projects for UMass Chemistry 423 Spring 2016
Introduction
(Laura) Background -types of cancer it is used to treat -How it works-Inhibits ALK (Anaplastic lymphoma kinase) -insert green scene of protein bound to ligand, linking on the word Inhibits -or possible green scene on ALK kinase itself
|
This is a sample scene created with SAT to by Group, and another to make of the protein.
Overall Structure
| |||||||||||
